Sense and nonsense of high-dose cytarabine for acute myeloid leukemia.

@article{Lwenberg2013SenseAN,
  title={Sense and nonsense of high-dose cytarabine for acute myeloid leukemia.},
  author={Bob L{\"o}wenberg},
  journal={Blood},
  year={2013},
  volume={121 1},
  pages={26-8}
}
High-dose cytarabine applied during remission induction or as consolidation after attainment of a complete remission has become an established element in the treatment of adults with acute myeloid leukemia. Recent evidence has challenged the need for these exceptionally high-dose levels of cytarabine. In this review, we present a reappraisal of the usefulness of high-dose cytarabine for acute myeloid leukemia treatment. 
Related Discussions
This paper has been referenced on Twitter 4 times. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 46 extracted citations

Frontline treatment of acute myeloid leukemia in adults.

Critical reviews in oncology/hematology • 2017
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 17 references

Cytarabine dose for acute myeloid leukemia.

The New England journal of medicine • 2011
View 1 Excerpt

Acute myeloid leukemia.

The New England journal of medicine • 1999

Similar Papers

Loading similar papers…